Blueprint Medicines Corp - Common Stock, par value $0.001 per share (BPMC)

317 filings reported holding BPMC - Blueprint Medicines Corp - Common Stock, par value $0.001 per share as of Q3 2021.
Blueprint Medicines Corp - Common Stock, par value $0.001 per share (BPMC) has 277 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 59,635,260 shares of 65,000,000 outstanding shares and own 91.75% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (5,583,132 shares), BlackRock Inc. (5,198,014 shares), PRICE T ROWE ASSOCIATES INC /MD/ (4,371,828 shares), FMR LLC (3,211,964 shares), WELLINGTON MANAGEMENT GROUP LLP (3,199,041 shares), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (1,717,164 shares), STATE STREET CORP (1,688,384 shares), Casdin Capital, LLC (1,550,000 shares), JPMORGAN CHASE & CO (1,517,811 shares), and TimesSquare Capital Management, LLC (1,468,545 shares).
This table shows the top 277 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.